Bill > SB1747

This bill amends Texas insurance law to enhance breast cancer screening coverage by defining and expanding provisions for screening mammograms, diagnostic imaging, and supplemental breast examinations. Specifically, the bill provides a more comprehensive definition of "diagnostic imaging" and introduces a new term "supplemental breast examination", both based on National Comprehensive Cancer Network guidelines. These definitions include various imaging techniques like contrast-enhanced mammography, breast ultrasound, magnetic resonance imaging, and molecular breast imaging, which can be used to evaluate breast abnormalities or assess cancer risk based on personal or family medical history. Most significantly, the bill prohibits health benefit plans from imposing any cost-sharing requirements (such as deductibles, copayments, or coinsurance) for these breast-related examinations, ensuring that patients can access these critical screenings without financial barriers. The bill will apply to health benefit plans delivered, issued, or renewed on or after January 1, 2026, and will take effect on September 1, 2025, giving insurance providers time to adjust their policies to comply with the new requirements.